A new test developed by Edmonton-based Innovotech Inc. (TSX VENTURE:IOT) will now allow doctors to more accurately identify the right antibiotics required to treat serious, chronic infections that are biofilm based. With more than 80 per cent of infections in the developed world caused by biofilms, the potential for this new breakthrough test, called bioFILM PATM, is of immense significance to the medical community.
(more...)